kras mutation and glutathion glynac Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients? Oncogenic Kras Maintains Pancreatic Tumors
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines Metabolomics Springer Nature Link Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





